ID
32451
Descripción
Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form defines when a subject should be excluded from the study or when a vaccination should be postponed. The form should be checked at each visit subsequent to the first visit.
Link
https://clinicaltrials.gov/ct2/show/NCT00241644
Palabras clave
Versiones (1)
- 1/11/18 1/11/18 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
1 de noviembre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644
Elimination Criteria
- StudyEvent: ODM
Descripción
Elimination Criteria During the Study
Alias
- UMLS CUI-1
- C0680251
Descripción
Use of investigational or non-registered product other than study vaccine
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0013230
- UMLS CUI [2,1]
- C0332300
- UMLS CUI [2,2]
- C1521826
- UMLS CUI [2,3]
- C0042210
Descripción
Chronic administration of immunosuppressants except topic
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0021081
- UMLS CUI [1,2]
- C0205191
- UMLS CUI [2,1]
- C0332300
- UMLS CUI [2,2]
- C1522168
- UMLS CUI [2,3]
- C0038317
Descripción
Administration of other vaccine
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2368628
- UMLS CUI [1,2]
- C0205394
Descripción
Administration of immunoglobulins or blood products
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0021027
- UMLS CUI [2]
- C0371802
Descripción
Contraindication to Subsequent Vaccination
Alias
- UMLS CUI-1
- C1301624
- UMLS CUI-2
- C0042196
Descripción
Hypersensitivity to vaccine
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C1521826
- UMLS CUI [1,3]
- C0042210
Descripción
Intussusception
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0021933
Descripción
The following AEs constitute contraindications to administration of HRV vaccine or placebo at that point in time; if any one of these AEs occurs at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol, or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE
Tipo de datos
float
Unidades de medida
- °C
Alias
- UMLS CUI [1]
- C0489749
- UMLS CUI [2]
- C1531924
Descripción
The following AEs constitute contraindications to administration of HRV vaccine or placebo at that point in time; if any one of these AEs occurs at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol, or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0017160
Similar models
Elimination Criteria
- StudyEvent: ODM
C0332300 (UMLS CUI [2,1])
C1521826 (UMLS CUI [2,2])
C0042210 (UMLS CUI [2,3])
C0205191 (UMLS CUI [1,2])
C0332300 (UMLS CUI [2,1])
C1522168 (UMLS CUI [2,2])
C0038317 (UMLS CUI [2,3])
C0205394 (UMLS CUI [1,2])
C0371802 (UMLS CUI [2])
C0042196 (UMLS CUI-2)
C1521826 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
C1531924 (UMLS CUI [2])